MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Tang, Wei ^a,b   Zhu, Jiujun ^a   Su, Shicheng ^a   Wu, Wei ^a   Liu, Qiang ^a   Su, Fengxi ^a   Yu, Fengyan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 27A; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER SURVIVAL; CANCER TISSUE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE MARKER; DISTANT METASTASIS; FEMALE; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; QUANTITATIVE ANALYSIS; SURVIVAL TIME; TUMOR GENE; TUMOR VOLUME; UPREGULATION; ZBTB10 GENE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MICRORNAS; MIDDLE AGED; PROGNOSIS; REPRESSOR PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84871116439     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051702     Document Type: Article

References (36)

1. Filipowicz W, Bhattacharyya SN, Sonenberg N, (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature reviews Genetics 9: 102-114.
2. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nature reviews Cancer 6: 259-269.
3. Wu F, Yang Z, Li G, (2009) Role of specific microRNAs for endothelial function and angiogenesis. Biochemical and biophysical research communications 386: 549-553.
4. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer research 65: 7065-7070.
5. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA: the journal of the American Medical Association 299: 425-436.
6. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, et al. (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer cell 13: 48-57.
7. Fulci V, Chiaretti S, Goldoni M, Azzalin G, Carucci N, et al. (2007) Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109: 4944-4951.
8. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, et al. (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochemical and biophysical research communications 334: 1351-1358.
9. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
10. Liu T, Tang H, Lang Y, Liu M, Li X, (2009) MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer letters 273: 233-242.
11. Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S, (2007) The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer research 67: 11001-11011.
12. Wang X, Tang S, Le SY, Lu R, Rader JS, et al. (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3: e2557.
13. Lerner M, Lundgren J, Akhoondi S, Jahn A, Ng HF, et al. (2011) MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression. Cell cycle 10: 2172-2183.
14. Zhang H, Li M, Han Y, Hong L, Gong T, et al. (2010) Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Digestive diseases and sciences 55: 2545-2551.
15. Li Z, Hu S, Wang J, Cai J, Xiao L, et al. (2010) MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells. Gynecologic oncology 119: 125-130.
16. Zhang Z, Liu S, Shi R, Zhao G, (2011) miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. Cancer genetics 204: 486-491.
17. Han BW, Feng DD, Li ZG, Luo XQ, Zhang H, et al. (2011) A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL. Human molecular genetics 20: 4903-4915.
18. Mertens-Talcott SU, Noratto GD, Li X, Angel-Morales G, Bertoldi MC, et al. (2012) Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: Role of Sp transcription factors and microRNA-27a:ZBTB10. Molecular carcinogenesis.
19. Banerjee N, Talcott S, Safe S, Mertens-Talcott SU, (2012) Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation. Breast cancer research and treatment 136: 21-34.
20. Scott GK, Mattie MD, Berger CE, Benz SC, Benz CC, (2006) Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer research 66: 1277-1281.
21. Abdelrahim M, Samudio I, Smith R 3rd, Burghardt R, Safe S (2002) Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells. The Journal of biological chemistry 277: 28815-28822.
22. Abdelrahim M, Baker CH, Abbruzzese JL, Safe S, (2006) Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation. Journal of the National Cancer Institute 98: 855-868.
23. Abdelrahim M, Smith R 3rd, Burghardt R, Safe S (2004) Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer research 64: 6740-6749.
24. Chintharlapalli S, Papineni S, Abdelrahim M, Abudayyeh A, Jutooru I, et al. (2009) Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells. International journal of cancer Journal international du cancer 125: 1965-1974.
25. Jutooru I, Chadalapaka G, Abdelrahim M, Basha MR, Samudio I, et al. (2010) Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a. Molecular pharmacology 78: 226-236.
26. Iyevleva AG, Kuligina E, Mitiushkina NV, Togo AV, Miki Y, et al. (2012) High level of miR-21, miR-10b, and miR-31 expression in bilateral vs. unilateral breast carcinomas. Breast cancer research and treatment 131: 1049-1059.
27. Zhao X, Yang L, Hu J, (2011) Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells. Journal of experimental & clinical cancer research: CR 30: 55.
28. Ma Y, Yu S, Zhao W, Lu Z, Chen J, (2010) miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer letters 298: 150-158.
29. Urbich C, Kaluza D, Fromel T, Knau A, Bennewitz K, et al. (2012) MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. Blood 119: 1607-1616.
30. Li X, Mertens-Talcott SU, Zhang S, Kim K, Ball J, et al. (2010) MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells. Endocrinology 151: 2462-2473.
31. Liu R, Zhang C, Hu Z, Li G, Wang C, et al. (2011) A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. European journal of cancer 47: 784-791.
32. Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, et al. (2012) miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer research 72: 1865-1877.
33. Chadalapaka G, Jutooru I, Safe S, (2012) Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells. Carcinogenesis 33: 886-894.
34. Guttilla IK, White BA, (2009) Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. The Journal of biological chemistry 284: 23204-23216.
35. Chintharlapalli S, Papineni S, Lei P, Pathi S, Safe S, (2011) Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and-independent downregulation of specificity proteins (Sp) transcription factors. BMC Cancer 11: 371.
36. Pathi SS, Jutooru I, Chadalapaka G, Sreevalsan S, Anand S, et al. (2011) GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway. Molecular cancer research: MCR 9: 195-202.